Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

GNLX

Genelux Corp

Nov 22 • 04:00PM ET

2.55

Dollar change +0.09
Percentage change 3.66	%

Healthcare • Biotechnology • USA • NASD

Peers: LLY VRTX MRNA REGN PFE NVS GILD BMY AMGN BIIB

| Held by: VTI VXF CNCR IWC CHNA BTEC

Index	-	P/E	-	EPS (ttm)	-0.95	Insider Own	19.60%	Shs Outstand	34.54M	Perf Week	8.05%
Market Cap	91.29M	Forward P/E	-	EPS next Y	-1.19	Insider Trans	-7.38%	Shs Float	27.77M	Perf Month	1.19%
Income	-27.66M	PEG	-	EPS next Q	-0.19	Inst Own	15.16%	Short Float	5.16%	Perf Quarter	17.51%
Sales	0.01M	P/S	9129.21	EPS this Y	23.62%	Inst Trans	16.19%	Short Ratio	8.07	Perf Half Y	-2.67%
Book/sh	0.96	P/B	2.66	EPS next Y	-34.03%	ROA	-74.41%	Short Interest	1.43M	Perf Year	-77.21%
Cash/sh	0.95	P/C	2.68	EPS next 5Y	-	ROE	-96.85%	52W Range	1.60 - 16.60	Perf YTD	-81.80%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.84%	ROI	-79.68%	52W High	-84.64%	Beta	-2.15
Dividend TTM	-	Quick Ratio	6.47	Sales past 5Y	-24.62%	Gross Margin	-10862.50%	52W Low	59.37%	ATR (14)	0.27
Dividend Ex-Date	-	Current Ratio	6.47	EPS Y/Y TTM	3.68%	Oper. Margin	-361862.50%	RSI (14)	44.80	Volatility	9.35% 10.74%
Employees	23	Debt/Eq	0.06	Sales Y/Y TTM	-96.64%	Profit Margin	-345750.00%	Recom	1.00	Target Price	18.40
Option/Short	No / Yes	LT Debt/Eq	0.05	EPS Q/Q	6.58%	Payout	-	Rel Volume	1.10	Prev Close	2.46
Sales Surprise	-	EPS Surprise	3.06%	Sales Q/Q	-	Earnings	Nov 14 AMC	Avg Volume	177.62K	Price	2.55
SMA20	-11.27%	SMA50	-3.53%	SMA200	-27.00%	Trades		Volume	194,543	Change	3.66%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-24	Initiated	Guggenheim	Buy	$8
Aug-28-24	Initiated	ROTH MKM	Buy	$10
Nov-27-23	Initiated	H.C. Wainwright	Buy	$35
Sep-12-23	Initiated	Maxim Group	Buy	$40
Feb-15-23	Initiated	The Benchmark Company	Speculative Buy	$10

Nov-15-24 09:50AM	These 2 Strong Buy Penny Stocks Are Set to Triple (or more), Say Analysts (TipRanks) -19.73%
Nov-14-24 04:05PM	Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Nov-06-24 04:01PM	Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference (GlobeNewswire)
Oct-25-24 01:01PM	Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp (GuruFocus.com)
Oct-23-24 11:27AM	Genelux doses first subject in Phase II trial of NSCLC treatment (Clinical Trials Arena)
04:01PM	Loading…
Oct-22-24 04:01PM	Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer (GlobeNewswire)
Oct-09-24 04:15PM	Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Sep-03-24 04:01PM	Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire) +13.94%
Aug-14-24 09:54PM	GNLX Stock Earnings: Genelux Beats EPS for Q2 2024 (InvestorPlace)
04:05PM	Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Aug-12-24 05:16PM	Genelux Corporation (GNLX): A Strong Buy According to Hedge Funds (Insider Monkey) -6.57%
Jul-30-24 07:00AM	Genelux Corporation to Participate in Fireside Chat at BTIG's Virtual Biotechnology Conference 2024 (GlobeNewswire)
May-24-24 08:00AM	Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants (GlobeNewswire) -43.04%
May-23-24 04:01PM	Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire) -5.35%
May-09-24 11:53PM	GNLX Stock Earnings: Genelux Misses EPS for Q1 2024 (InvestorPlace) +6.07%
04:25PM	Loading…
04:25PM	Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Apr-26-24 09:35AM	Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:35AM	Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-05-24 09:35AM	After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX) (Zacks)
Apr-04-24 12:00PM	All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy (Zacks)
Apr-02-24 07:52AM	GNLX Stock Earnings: Genelux Misses EPS for Q4 2023 (InvestorPlace)
Apr-01-24 07:00AM	Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -18.51%
Dec-15-23 03:01PM	Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX) (GuruFocus.com) -13.23%
Nov-27-23 07:00AM	Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer (GlobeNewswire)
Nov-14-23 05:50PM	Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates (GlobeNewswire) -7.61%
Oct-20-23 01:22PM	12 Best Performing Biotech Stocks in 2023 (Insider Monkey)
Oct-11-23 09:00AM	Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment (PR Newswire)
Sep-19-23 03:01PM	Director John Thomas Sells 6667 Shares of Genelux Corp (GNLX) (GuruFocus.com) +8.04%
Sep-15-23 03:03PM	Director John Smither Sells 900 Shares of Genelux Corp (GNLX) (GuruFocus.com)
Sep-14-23 01:21PM	10% Owner Aladar Szalay Sells 52,616 Shares of Genelux Corp (GNLX) (GuruFocus.com)
07:00AM	Loading…
07:00AM	Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-07-23 04:01PM	Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire) -6.69%
Aug-28-23 07:00AM	Genelux Corporation Announces New Chief Financial Officer (GlobeNewswire) +11.01%
Aug-14-23 07:00AM	Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates (GlobeNewswire)
Aug-02-23 04:00PM	Genelux Corporation to Participate in Fireside Chat at BTIGs Virtual Biotechnology Conference 2023 (GlobeNewswire) +5.52%
01:08AM	10 Recent IPOs in 2023 to Consider (Insider Monkey)
Jul-28-23 10:54AM	Why Shares of Genelux Climbed This Week (Motley Fool) -9.38%
Jul-20-23 04:45PM	Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires (GlobeNewswire) -10.85% -15.77%
Jul-10-23 07:00AM	Genelux Corporation Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec in Patients with Malignant Pleural Effusion from Mesothelioma, Lung or Breast Cancers in Frontiers in Immunology (GlobeNewswire)
Jun-29-23 07:00AM	Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics, LLC (GlobeNewswire)
Jun-22-23 07:00AM	Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023 (GlobeNewswire) -7.05%
Jun-12-23 07:00AM	Genelux Corporation Announces $18 Million Private Placement (GlobeNewswire) +7.58%
Jun-01-23 05:19PM	Why Shares of Genelux Corporation Jumped This Week (Motley Fool) +6.62%
May-25-23 04:01PM	Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JAMA) Oncology (GlobeNewswire) +6.62%
May-15-23 07:00AM	Genelux Corporation Announces $33 Million Private Placement (GlobeNewswire) -9.06%
Mar-23-23 07:00AM	Genelux Corporation to Ring Nasdaq Opening Bell on March 29, 2023 (GlobeNewswire)
Jan-25-23 09:00PM	Genelux Corporation Announces Pricing of Initial Public Offering (GlobeNewswire)

Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Szalay Aladar	10% Owner	Sep 12 '24	Sale	2.73	31,777	86,732	632,901	Sep 13 06:22 PM
Szalay Aladar	10% Owner	Sep 13 '24	Sale	2.57	33,080	84,946	599,821	Sep 13 06:22 PM
Tyree James L	Director	Sep 11 '24	Sale	2.60	1,730	4,499	47,521	Sep 12 08:40 PM
Szalay Aladar	10% Owner	Sep 11 '24	Sale	2.62	31,376	82,227	664,678	Sep 11 06:23 PM
Szalay Aladar	10% Owner	Sep 09 '24	Sale	2.70	23,383	63,200	716,438	Sep 11 06:23 PM
Szalay Aladar	10% Owner	Sep 10 '24	Sale	2.51	20,384	51,182	696,054	Sep 11 06:23 PM
JAMES L TYREE	Director	Sep 11 '24	Proposed Sale	2.51	1,730	4,342		Sep 11 04:20 PM
SZALAY 2010 RETAINED ANNUITY T	10% Owner	Sep 09 '24	Proposed Sale	2.80	140,000	392,000		Sep 06 07:00 PM
Szalay Aladar	10% Owner	Sep 03 '24	Sale	2.09	42,818	89,614	739,821	Sep 06 05:08 PM
Szalay Aladar	10% Owner	Aug 30 '24	Sale	2.17	142,589	309,846	782,639	Aug 30 07:58 PM
Szalay Aladar	10% Owner	Aug 29 '24	Sale	1.98	107,045	211,960	925,228	Aug 30 07:58 PM
Szalay Aladar	10% Owner	Aug 28 '24	Sale	2.05	15,918	32,605	1,032,273	Aug 30 07:58 PM
Szalay Aladar	10% Owner	Aug 27 '24	Sale	2.11	51,630	108,862	1,048,191	Aug 27 07:23 PM
Szalay Aladar	10% Owner	Aug 23 '24	Sale	2.29	40,000	91,416	1,099,821	Aug 27 07:23 PM
SZALAY 2010 RETAINED ANNUITY T	10% Owner	Aug 23 '24	Proposed Sale	2.18	400,000	872,000		Aug 22 05:08 PM
Yu Yong	VP, Clinical Trial Operations	Jun 24 '24	Sale	2.12	6,849	14,520	10,869	Jul 08 04:30 PM
Ryder Sean	General Counsel	Jun 24 '24	Sale	2.12	5,496	11,652	19,388	Jul 08 04:30 PM
Jewett Caroline	Head of Quality	Jun 24 '24	Sale	2.12	4,961	10,517	16,174	Jul 08 04:30 PM
Szalay Aladar	10% Owner	May 15 '24	Sale	3.66	17,094	62,624	1,139,821	May 15 05:59 PM
Szalay Aladar	10% Owner	May 14 '24	Sale	3.58	15,426	55,274	1,156,915	May 15 05:59 PM
Szalay Aladar	10% Owner	May 13 '24	Sale	3.62	3,446	12,478	1,172,341	May 15 05:59 PM
Szalay Aladar	10% Owner	May 08 '24	Sale	3.82	13,919	53,189	1,175,787	May 09 04:38 PM
Szalay Aladar	10% Owner	May 07 '24	Sale	3.67	6,025	22,111	1,189,706	May 09 04:38 PM
Szalay Aladar	10% Owner	May 01 '24	Sale	3.30	33,061	109,161	1,195,731	May 01 06:16 PM
Szalay Aladar	10% Owner	Apr 30 '24	Sale	3.12	20,535	63,981	1,228,792	May 01 06:16 PM
Szalay Aladar	10% Owner	Apr 29 '24	Sale	3.25	6,403	20,792	1,249,327	May 01 06:16 PM
Szalay Aladar	10% Owner	Apr 23 '24	Sale	3.49	22,000	76,800	1,263,794	Apr 24 05:50 PM
Szalay Aladar	10% Owner	Apr 22 '24	Sale	3.53	14,331	50,597	1,285,794	Apr 24 05:50 PM
Szalay Aladar	10% Owner	Apr 24 '24	Sale	3.50	8,064	28,251	1,255,730	Apr 24 05:50 PM
Szalay Aladar	10% Owner	Apr 16 '24	Sale	3.53	48,683	171,802	1,322,862	Apr 18 05:00 PM
Szalay Aladar	10% Owner	Apr 17 '24	Sale	3.71	22,737	84,425	1,300,125	Apr 18 05:00 PM
Yu Yong	VP, Clinical Trial Operations	Dec 15 '23	Sale	13.16	32,535	428,180	0	Dec 18 04:15 PM
Tyree James L	Director	Dec 13 '23	Sale	13.22	9,000	118,969	3,460	Dec 14 08:59 PM
Thomas John	Director	Dec 13 '23	Sale	13.38	9,000	120,387	463,460	Dec 14 08:58 PM
Yu Yong	VP, Clinical Trial Operations	Dec 07 '23	Sale	11.85	36,800	435,995	32,535	Dec 08 05:57 PM

Dollar change -0.0249
Percentage change -2.58	%

ASRT Assertio Holdings Inc daily Stock Chart

Peers: SFM OIS DCTH HRTX PBPB MYE OPI NUS FET TSE

| Held by: VTI VXF PRFZ BSVO EES SQLV ITOT RFLR

Index	-	P/E	-	EPS (ttm)	-0.72	Insider Own	6.81%	Shs Outstand	94.67M	Perf Week	15.95%
Market Cap	87.51M	Forward P/E	-	EPS next Y	-0.08	Insider Trans	1.96%	Shs Float	88.97M	Perf Month	-5.21%
Income	-68.49M	PEG	-	EPS next Q	-0.04	Inst Own	31.11%	Short Float	6.84%	Perf Quarter	-24.74%
Sales	125.76M	P/S	0.70	EPS this Y	-129.09%	Inst Trans	-25.13%	Short Ratio	10.31	Perf Half Y	-5.92%
Book/sh	1.37	P/B	0.69	EPS next Y	50.00%	ROA	-20.88%	Short Interest	6.09M	Perf Year	-24.13%
Cash/sh	0.95	P/C	0.99	EPS next 5Y	10.00%	ROE	-42.36%	52W Range	0.73 - 1.80	Perf YTD	-12.07%
Dividend Est.	-	P/FCF	4.28	EPS past 5Y	-	ROI	-38.10%	52W High	-47.68%	Beta	0.82
Dividend TTM	-	Quick Ratio	1.57	Sales past 5Y	-7.51%	Gross Margin	51.18%	52W Low	28.45%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	2.01	EPS Y/Y TTM	51.98%	Oper. Margin	-11.30%	RSI (14)	45.84	Volatility	11.69% 8.78%
Employees	53	Debt/Eq	0.38	Sales Y/Y TTM	-25.77%	Profit Margin	-54.46%	Recom	1.00	Target Price	2.79
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	99.11%	Payout	-	Rel Volume	1.18	Prev Close	0.97
Sales Surprise	1.16%	EPS Surprise	34.78%	Sales Q/Q	-18.03%	Earnings	Nov 11 AMC	Avg Volume	590.87K	Price	0.94
SMA20	-2.06%	SMA50	-12.78%	SMA200	-13.98%	Trades		Volume	697,714	Change	-2.58%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Initiated	Maxim Group	Buy	$3
Jul-03-24	Initiated	H.C. Wainwright	Buy	$4
Nov-07-22	Initiated	Lake Street	Buy	$7
Nov-30-18	Downgrade	Mizuho	Buy → Neutral

Nov-15-24 09:00AM	Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio (Business Wire)
Nov-12-24 09:41AM	Q3 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -7.89%
Nov-11-24 04:09PM	Assertio: Q3 Earnings Snapshot (Associated Press Finance) +8.82%
04:02PM	Assertio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
03:41PM	Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio (Business Wire)
07:30AM	Loading…
07:30AM	Assertio Provides Response to Letter from Short-seller (GlobeNewswire)
Nov-08-24 09:00AM	Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud (Business Wire) -15.84%
07:06AM	Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-30-24 08:00AM	Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024 (GlobeNewswire)
Oct-11-24 08:00AM	Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 (GlobeNewswire)
Oct-09-24 05:18PM	Assertio Holdings Inc (ASRT) Q2 2024 Earnings Call Highlights: Navigating Sales Challenges and ... (GuruFocus.com)
Oct-04-24 04:05PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-03-24 04:05PM	Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024 (GlobeNewswire) -5.93% +10.81%
Aug-07-24 04:47PM	Assertio: Q2 Earnings Snapshot (Associated Press Finance) -11.79%
04:01PM	Assertio Reports Second Quarter 2024 Financial Results (GlobeNewswire)
04:05PM	Loading…
Jul-24-24 04:05PM	Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire) -6.17%
09:00AM	Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc. (Business Wire)
Jul-09-24 04:30PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +8.11%
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-06-24 04:05PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-24 08:30AM	Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024 (GlobeNewswire)
May-29-24 07:00AM	Assertio Announces the Appointment of Brendan P. O'Grady as New CEO (GlobeNewswire)
May-17-24 09:15AM	Assertio to Participate in Benchmark Healthcare Conference on May 21-22 (GlobeNewswire)
07:30AM	BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS (PR Newswire)
May-16-24 09:16AM	Assertio to Participate in AGP Healthcare Conference on May 21 (GlobeNewswire)
May-13-24 05:52PM	BUXTON HELMSLEY URGES ASSERTIO STOCKHOLDERS TO VOTE 'AGAINST' DIRECTORS AFTER DISCLOSURE FAILURES, INAPPROPRIATE BOARDROOM ACTIVITY, STRATEGIC BLUNDERS (PR Newswire) +9.38%
May-10-24 03:12PM	Assertio to Present at the Citizens JMP Life Sciences Conference in New York City (GlobeNewswire) -8.57%
May-07-24 10:28AM	Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.02%
05:35AM	Q1 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:10AM	Assertio Holdings Inc (ASRT) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ... (GuruFocus.com)
08:59PM	Loading…
May-06-24 08:59PM	ASRT Stock Earnings: Assertio Holdings Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +18.45%
05:46PM	Assertio Holdings Inc (ASRT) Surpasses Revenue Estimates But Reports Wider Loss in Q1 2024 (GuruFocus.com)
04:21PM	Assertio: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 08:00AM	Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024 (GlobeNewswire) -9.30%
Apr-03-24 08:00AM	Sig Kirk Joins Assertio Board of Directors (GlobeNewswire)
Apr-01-24 09:00AM	Assertio to Present at LD Micro Invitational Conference in New York City (GlobeNewswire)
Mar-12-24 11:11AM	Assertio Holdings Inc (ASRT) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com) +8.06%
08:31AM	Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:49AM	Q4 2023 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-11-24 04:26PM	Assertio: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 05:07PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Feb-29-24 04:05PM	Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024 (GlobeNewswire)
Feb-28-24 10:15AM	Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Investors of March 5, 2024 Lead Plaintiff Deadline and Urges Investors with Substantial Losses to Contact the Firm (PR Newswire)
Feb-26-24 07:57PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Feb-23-24 11:30AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
05:45AM	Investors in Assertio Holdings, Inc. Should Contact Levi & Korsinsky Before March 5, 2024 to Discuss Your Rights - ASRT (PR Newswire)
Feb-22-24 12:35PM	Assertio Holdings, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information ASRT (GlobeNewswire)
Feb-19-24 12:39PM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Feb-16-24 12:41PM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire)
11:28AM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Feb-13-24 05:45AM	Shareholders of Assertio Holdings, Inc. Should Contact Levi & Korsinsky Before March 5, 2024 to Discuss Your Rights - ASRT (PR Newswire) -7.27%
Feb-12-24 10:30AM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire) +7.90%
Feb-09-24 02:51PM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Feb-05-24 03:56PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:24AM	Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why (Zacks)
10:08AM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Feb-02-24 12:32PM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire)
12:19PM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Jan-29-24 12:30PM	Assertio Holdings (ASRT) Faces Lawsuit, Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire) +5.96%
Jan-26-24 09:15AM	Analyst Slashes Assertio Holdings (ASRT) Price Target Amid CEO's Departure and Securities Fraud Suit Hagens Berman (GlobeNewswire)
Jan-24-24 06:54PM	Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:15AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-22-24 03:42PM	Assertio Holdings (ASRT) Faces Lawsuit as Analyst Slashes Price Target Amid CEO's Departure Hagens Berman (GlobeNewswire)
Jan-19-24 09:36AM	Assertio Holdings, Inc. (NASDAQ: ASRT) Securities Fraud: Contact Berger Montague To Discuss Your Rights (GlobeNewswire)
Jan-17-24 10:15AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
09:35AM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Jan-15-24 03:29PM	Assertio Holdings (ASRT) Faces Lawsuit After CEO Sacked Hagens Berman (GlobeNewswire)
Jan-10-24 10:45AM	ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-08-24 12:14PM	Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire) -5.39%
Jan-05-24 06:56PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +12.79%
Jan-04-24 09:46AM	Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO (Zacks) -10.91%
Jan-03-24 08:59AM	Assertio Holdings, Inc. Announces Leadership Transition (GlobeNewswire) -10.96%
Dec-25-23 02:06PM	Pre-Surge Penny Picks: 3 Stocks to Buy Before They Boom (InvestorPlace)
Nov-14-23 08:00AM	Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors (GlobeNewswire)
Nov-10-23 01:11PM	Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.44%
Nov-09-23 08:49AM	Q3 2023 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -43.19%
Nov-08-23 06:46PM	Assertio Holdings Inc (ASRT) Faces Headwinds in Q3 2023 Despite Revenue Growth (GuruFocus.com)
04:30PM	Assertio: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 12:06PM	Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023 (GlobeNewswire)
Oct-06-23 04:30PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-22-23 08:38AM	Is the Options Market Predicting a Spike in Assertio (ASRT) Stock? (Zacks)
Sep-14-23 01:12PM	Insider Sell: SVP, General Counsel Sam Schlessinger Sells 45,236 Shares of Assertio Holdings Inc (GuruFocus.com) -5.44%
Aug-28-23 06:30PM	12 Best High Risk Penny Stocks to Buy Now (Insider Monkey)
Aug-25-23 04:05PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-23-23 08:48AM	Is the Options Market Predicting a Spike in Assertio (ASRT) Stock? (Zacks)
Aug-08-23 04:45PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) -7.27%
09:15AM	Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline (Newsfile)
Aug-06-23 08:05AM	Industry Analysts Just Upgraded Their Assertio Holdings, Inc. (NASDAQ:ASRT) Revenue Forecasts By 13% (Simply Wall St.)
07:14AM	10 Oversold Value Stocks To Buy (Insider Monkey)
Aug-03-23 04:29PM	Assertio: Q2 Earnings Snapshot (Associated Press Finance) -45.61%
04:04PM	Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition (GlobeNewswire)
Jul-31-23 07:27PM	Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction (GlobeNewswire) -5.45%
Jul-27-23 04:01PM	Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals (GlobeNewswire) +6.37%
Jul-24-23 08:30AM	Assertio Holdings, Inc. to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023 (GlobeNewswire) +6.17%
Jul-19-23 07:38AM	Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? (Simply Wall St.)
Jul-07-23 09:16AM	3 Cheap Penny Stocks to Buy Before They Bounce Back (InvestorPlace)
Jun-26-23 07:00AM	Assertio Holdings Joins Russell 3000® Index (GlobeNewswire)

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mason Heather L	Director	Nov 18 '24	Buy	0.80	75,000	60,000	287,650	Nov 19 09:02 AM
O'Grady Brendan P.	CEO	Nov 14 '24	Buy	0.85	11,706	9,950	11,706	Nov 15 02:43 PM
Schlessinger Sam	SVP, General Counsel	Oct 01 '24	Option Exercise	0.00	19,404	0	141,459	Oct 03 07:00 PM
Vacirca Jeff L	Director	Jun 11 '24	Buy	1.11	10,000	11,100	151,159	Jun 12 06:00 PM
Mason Heather L	Interim Executive Officer	Jun 05 '24	Buy	0.97	25,000	24,250	212,650	Jun 06 06:00 PM
Schlessinger Sam	SVP, General Counsel	May 12 '24	Option Exercise	0.00	38,017	0	138,895	May 14 08:01 PM
Schwichtenberg Paul	SVP, CCO	May 12 '24	Option Exercise	0.00	38,017	0	141,941	May 14 08:01 PM
Patel Ajay	SVP and CFO	May 12 '24	Option Exercise	0.00	38,017	0	171,271	May 14 08:00 PM
Tyree James L	Director	Mar 14 '24	Sale	1.12	10,251	11,463	188,251	Mar 15 08:01 PM
Schlessinger Sam	SVP, General Counsel	Feb 21 '24	Option Exercise	0.00	17,151	0	109,384	Feb 23 05:32 PM
Schwichtenberg Paul	SVP, CCO	Feb 21 '24	Option Exercise	0.00	17,151	0	112,430	Feb 23 05:31 PM
Patel Ajay	SVP and CFO	Feb 21 '24	Option Exercise	0.00	17,151	0	141,760	Feb 23 05:30 PM
Schlessinger Sam	SVP, General Counsel	Feb 11 '24	Option Exercise	0.00	18,939	0	98,785	Feb 13 07:02 PM
Schwichtenberg Paul	See Remarks	Feb 11 '24	Option Exercise	0.00	47,348	0	111,661	Feb 13 07:01 PM
Patel Ajay	SVP and CFO	Feb 11 '24	Option Exercise	0.00	47,348	0	140,991	Feb 13 07:00 PM

GNLX

Genelux Corp

ASRT

Assertio Holdings Inc

Upgrade your FINVIZ experience